April 29, 2021 – At MetroHealth in Cleveland, the health providers and the staff who support them work as one to meet the health system’s mission of “leading the way to a healthier you and a healthier community.” One of the key elements that helps turn these words into action is the 340B drug pricing program. MetroHealth is a system with four hospitals, more than 20 health … [Read more...]
Senate Report Blasts Insulin Makers for High Prices
January 21, 2021– A new, bipartisan report from a key congressional committee is sharply critical of the three major drug manufacturers that sell insulin in the U.S. The companies – Eli Lilly, Novo Nordisk, and Sanofi – already have been all over the news recently for their pricing behavior. They also are the ringleaders of a group of drug companies that are circumventing … [Read more...]
Keeping Diabetes in Check With 340B’s Help
November 25, 2020 – Chicago patient Hanan Tadros was struggling to manage her diabetes and her multiple other chronic conditions. That all started to change when she received diabetes education and medication therapy management services at UI Health in Chicago, resources available through the 340B drug pricing program. “They taught me how to take my insulin and they taught … [Read more...]
Faces of 340B: A Prescription for Improved Quality of Life
July 20, 2020— A decade-and-a-half ago, Chicago patient Hanan Tadros was feeling overwhelmed. She was struggling to manage her multiple chronic health conditions and juggle her more than 10 prescription medications for diabetes, depression, and more. That’s when a hospital participating in the 340B drug pricing program intervened to help change her life for the … [Read more...]
Faces of 340B: Putting Insulin Within Reach
May 15, 2020 – Patient Debra Abercrumbie remembers that when she first came to MetroHealth in Cleveland, her hemoglobin A1C levels were “out of control,” and she would need to start managing them better if she were going to improve her health while living with her diabetes. Fortunately, MetroHealth had the medication assistance and care coordination that she required, in large … [Read more...]
340B Means Better Diabetes Care
May 8, 2020— The threat of chronic diseases such as diabetes has not taken a break during the nation’s response to the COVID-19 pandemic. More than one in 10 Americans are living with diabetes, with typically underserved populations hit hard not only by the disease but also by the life-threatening complications that can come with it. The pandemic only serves to make the … [Read more...]
The 340B Proof of Concept: Better Patient Health
December 5, 2019– When policymakers assess whether programs they created are having positive impacts on people and communities, they ask for evidence that things are better than they were before the program took effect. When it comes to the 340B drug pricing program, that proof is in the improved health of patients. A new report by 340B Health has important information about … [Read more...]